Tandem Diabetes Care (MEX:TNDM) Tax Provision: MXN-40 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TNDM Tandem Diabetes Care Inc MEX:TNDM
64 GF Score
Price MXN745.00
GF Value MXN1,048.05
! 5 Warning Signs
View Full Analysis

What is Tandem Diabetes Care Tax Provision?

Tandem Diabetes Care MEX:TNDM 64 Tax Provision is MXN-40 Mil as of Jun. 2026. GuruFocus rates MEX:TNDM with a GF Score™ of 64/100 and a GF Value™ of MXN1,048.05. The stock has 5 warning signs investors should review.

Tandem Diabetes Care's tax provision for the three months ended in Jun. 2026 was MXN-9 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-40 Mil.

Tandem Diabetes Care Tax Provision Historical Data

* Premium members only.

The historical data trend for Tandem Diabetes Care's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tandem Diabetes Care Tax Provision Chart

Tandem Diabetes Care Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.87 -33.96 -40.01 -86.66 -79.91

Tandem Diabetes Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.21 72.97 -94.91 -9.31 -8.90
MEX:TNDM
64GF Score
Tandem Diabetes Care Inc MEX:TNDM
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tandem Diabetes Care Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of MXN-40 Mil mean?
Tandem Diabetes Care (MEX:TNDM) has a Tax Provision of MXN-40 Mil as of Jun. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Tandem Diabetes Care and its competitors.
Is Tandem Diabetes Care's Tax Provision too high?
Tandem Diabetes Care's current Tax Provision is MXN-40 Mil. Overall, Tandem Diabetes Care has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Tandem Diabetes Care's Tax Provision compare to CNMD and ATEC?
Tandem Diabetes Care's Tax Provision of MXN-40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Medical Devices & Instruments company?
A good Tax Provision depends on the Medical Devices & Instruments industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Tandem Diabetes Care and its competitors. Tandem Diabetes Care's current Tax Provision is MXN-40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tandem Diabetes Care stock overvalued right now?
Tandem Diabetes Care (MEX:TNDM) has a current Tax Provision of MXN-40 Mil. The stock's GF Value™ is MXN1,048.05, compared to a current price of MXN745.00 — trading 28.9% below its estimated fair value. The current Tax Provision is MXN-40 Mil. Tandem Diabetes Care's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Tandem Diabetes Care (MEX:TNDM), the current Tax Provision is MXN-40 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tandem Diabetes Care (MEX:TNDM) Overvalued in 2026?

Based on GuruFocus' analysis, Tandem Diabetes Care stock appears to be undervalued. The current stock price of MXN745.00 is trading 28.9% below its estimated GF Value™ of MXN1,048.05.

Key valuation signals for MEX:TNDM:

  • Tax Provision: MXN-40 Mil
  • GF Value™: MXN1,048.05 vs. price of MXN745.00 (28.9% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the MEX:TNDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tandem Diabetes Care Business Description

Address 12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
64GF Score

Get the complete analysis for MEX:TNDM

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN745.00
Price
MXN1,048.05
GF Value